| | | | | | | | | | |
|
|
| Dockets Entered
On April 7, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1992S-0251
|
| Electronic Submissions; Establishment of Public Docket
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2002F-0181
|
| Use of cetylpyridinium chloride as an antimicrobial
|
|
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
| 2003Q-0401
|
| Qualified Health Claim (QHC) Omega-3 Fatty Acids and Coronoary Heart Disease Health Claim
|
|
|
| 2004D-0042
|
| Guidances for Industry on Improving Direct-to-Consumer Advertising for Medical Products
|
|
|
| 2004Q-0102
|
| Qualified Health Claim: Calcium and Kidney/urinary stones
|
|
|
| 2004Q-0144
|
| Qualified Health Claim (QHC): Chromium picolinate and Diabetes
|
|
|
| 1992S-0251
|
| Electronic Submissions; Establishment of Public Docket
|
|
|
| M
30
|
| New Drug Application/Abbreviated New Drug Application - Annual Reports
|
| Vol #:
|
| 1
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| EMC 5646
|
| M. Schneider
|
| Vol #:
|
| 210
|
|
|
| EMC 5647
|
| G. Fellman
|
| Vol #:
|
| 210
|
|
|
| EMC 5648
|
| N. DeFelice
|
| Vol #:
|
| 210
|
|
|
| EMC 5649
|
| J. Hammond
|
| Vol #:
|
| 210
|
|
|
| EMC 5650
|
| J. Berlin
|
| Vol #:
|
| 210
|
|
|
| EMC 5651
|
| T. Whited
|
| Vol #:
|
| 210
|
|
|
| EMC 5652
|
| C. Kistner
|
| Vol #:
|
| 210
|
|
|
| EMC 5653
|
| F.Hernandez
|
| Vol #:
|
| 210
|
|
|
| EMC 5654
|
| P. Eicher
|
| Vol #:
|
| 210
|
|
|
| EMC 5655
|
| S. Datz
|
| Vol #:
|
| 210
|
|
|
| EMC 5656
|
| B. & J. Stanton
|
| Vol #:
|
| 210
|
|
|
| EMC 5657
|
| J. Johnson
|
| Vol #:
|
| 210
|
|
|
| EMC 5658
|
| B. Saver
|
| Vol #:
|
| 210
|
|
|
| EMC 5659
|
| M. PetKov
|
| Vol #:
|
| 210
|
|
|
| EMC 5660
|
| J. Rhodes-Knowlton
|
| Vol #:
|
| 210
|
|
|
| EMC 5661
|
| S. Mullins
|
| Vol #:
|
| 210
|
|
|
| EMC 5662
|
| S. Isbister
|
| Vol #:
|
| 210
|
|
|
| EMC 5663
|
| B. Hooker
|
| Vol #:
|
| 210
|
|
|
| EMC 5664
|
| W. Bodden
|
| Vol #:
|
| 210
|
|
|
| EMC 5665
|
| A. Folland
|
| Vol #:
|
| 210
|
|
|
| EMC 5666
|
| T. Baker
|
| Vol #:
|
| 210
|
|
|
| EMC 5667
|
| M. West
|
| Vol #:
|
| 210
|
|
|
| EMC 5668
|
| R. Vanderleelie
|
| Vol #:
|
| 210
|
|
|
| EMC 5669
|
| K. Eddy
|
| Vol #:
|
| 210
|
|
| | | | | | | | |
|
|
| CS
2
|
| HFA-305 to Henry E. Schwartz
|
| Vol #:
|
| 2
|
|
|
| OR
2
|
| HF-3
|
| Vol #:
|
| 2
|
|
|
| 2003Q-0401
|
| Qualified Health Claim (QHC) Omega-3 Fatty Acids and Coronoary Heart Disease Health Claim
|
|
|
| EMC
2
|
| Kraft Foods Global Inc
|
| Vol #:
|
| 2
|
|
|
| SUP
2
|
| Martek Biosciences Corporation
|
| Vol #:
|
| 2
|
|
|
| 2004D-0042
|
| Guidances for Industry on Improving Direct-to-Consumer Advertising for Medical Products
|
|
|
| EXT
1
|
| Advanced Medical Technology Association (AdvaMed)
|
| Vol #:
|
| 1
|
|
|
| 2004Q-0102
|
| Qualified Health Claim: Calcium and Kidney/urinary stones
|
|
|
| ACK
2
|
| HFS-200 to Emord and Associates PC
|
| Vol #:
|
| 6
|
|
|
| 2004Q-0144
|
| Qualified Health Claim (QHC): Chromium picolinate and Diabetes
|
|
|
| ACK
1
|
| HFS-830 to Emord & Associates, PC
|
| Vol #:
|
| 11
|
|
|
| QHC
1
|
| Nutrition 21, Inc.
|
| Vol #:
|
| 1
|
|